Geode Capital Management, LLC Cyma Bay Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.26 Trillion
Q4 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$12.63 - $24.47 $3.85 Million - $7.45 Million	304,549 Added 14.67%	2,380,105 $56.2 Million
Q3 2023 Nov 13, 2023	BUY	$10.86 - $17.62 $2.39 Million - $3.88 Million	220,086 Added 11.86%	2,075,556 $30.9 Million
Q2 2023 Aug 11, 2023	BUY	$7.47 - $10.95 $7.1 Million - $10.4 Million	950,512 Added 105.03%	1,855,470 $20.3 Million
Q1 2023 May 15, 2023	BUY	$5.88 - $9.59 $676,458 - $1.1 Million	115,044 Added 14.56%	904,958 $7.89 Million
Q4 2022 Feb 13, 2023	BUY	$3.22 - $6.27 $15,935 - $31,030	4,949 Added 0.63%	789,914 $4.95 Million
Q3 2022 Nov 14, 2022	BUY	$2.77 - $4.25 $200,511 - $307,644	72,387 Added 10.16%	784,965 $2.75 Million
Q2 2022 Aug 12, 2022	SELL	$1.72 - $3.39 $1.04 Million - $2.05 Million	-604,370 Reduced 45.89%	712,578 $2.1 Million
Q1 2022 May 13, 2022	BUY	$2.77 - $3.64 $459,108 - $603,304	165,743 Added 14.4%	1,316,948 $4.1 Million
Q4 2021 Feb 11, 2022	BUY	$3.23 - $4.6 $142,488 - $202,924	44,114 Added 3.98%	1,151,205 $3.89 Million
Q3 2021 Nov 12, 2021	SELL	$3.47 - $4.42 $133,643 - $170,231	-38,514 Reduced 3.36%	1,107,091 $4.04 Million
Q2 2021 Aug 13, 2021	SELL	$3.94 - $4.92 $44,793 - $55,935	-11,369 Reduced 0.98%	1,145,605 $4.99 Million
Q1 2021 May 12, 2021	BUY	$4.23 - $6.55 $496,640 - $769,028	117,409 Added 11.29%	1,156,974 $5.25 Million
Q4 2020 Feb 12, 2021	BUY	$5.73 - $9.03 $130,729 - $206,019	22,815 Added 2.24%	1,039,565 $5.97 Million
Q3 2020 Nov 13, 2020	SELL	$3.32 - $7.24 $130,319 - $284,191	-39,253 Reduced 3.72%	1,016,750 $7.36 Million
Q2 2020 Aug 13, 2020	SELL	$1.41 - $4.25 $43,963 - $132,515	-31,180 Reduced 2.87%	1,056,003 $3.69 Million
Q1 2020 May 14, 2020	BUY	$1.25 - $2.02 $74,078 - $119,711	59,263 Added 5.77%	1,087,183 $1.61 Million
Q4 2019 Feb 13, 2020	BUY	$1.33 - $5.93 $125,440 - $559,293	94,316 Added 10.1%	1,027,920 $2.01 Million
Q3 2019 Nov 12, 2019	BUY	$5.12 - $7.21 $270,801 - $381,344	52,891 Added 6.01%	933,604 $4.78 Million
Q2 2019 Aug 14, 2019	BUY	$6.05 - $13.66 $633,029 - $1.43 Million	104,633 Added 13.48%	880,713 $6.31 Million
Q1 2019 May 14, 2019	BUY	$8.16 - $13.42 $1.23 Million - $2.02 Million	150,453 Added 24.05%	776,080 $10.3 Million
Q4 2018 Feb 13, 2019	BUY	$6.54 - $11.74 $211,483 - $379,636	32,337 Added 5.45%	625,627 $4.92 Million
Q3 2018 Nov 13, 2018	BUY	$10.88 - $14.52 $350,629 - $467,936	32,227 Added 5.74%	593,290 $6.57 Million
Q2 2018 Aug 14, 2018	BUY	$10.66 - $14.38 $1.92 Million - $2.59 Million	180,004 Added 47.24%	561,063 $7.53 Million
Q1 2018 May 15, 2018	BUY	$9.0 - $15.16 $907,164 - $1.53 Million	100,796 Added 35.96%	381,059 $4.95 Million
Q3 2017 Nov 14, 2017	BUY	$5.95 - $8.26 $679,144 - $942,812	114,142 Added 68.71%	280,263 $2.26 Million
Q2 2017 Aug 14, 2017	BUY	N/A	166,121	166,121 $956,000

Others Institutions Holding CBAY

# of Institutions

Shares Held

1.82M

Call Options Held

Put Options Held

View Full List

About CymaBay Therapeutics, Inc.

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

More about CBAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account